Opioid Use For Chronic Pain Would Be Restricted Under CDC Guideline
This article was originally published in The Pink Sheet Daily
Executive Summary
Draft guideline recommends limiting dosing to equivalent of 90 mg of morphine per day and limiting use to three days after acute injury.
You may also be interested in...
CDC Advises Against Use Of Extended Release Opioids, Redefines High Dose
New clinical practice guideline recommends immediate-release opioids instead of extended-release and long-acting opioids when starting pain therapy. It specifies high dose is 50 mg morphine equivalent dose (MME) per day or higher. The 2016 guideline had set it at 90 MME/day.
Opioid Indication Change Could Draw Legal Challenge From Physicians Group Seeking More Restrictions
FDA tells sponsors to revise the indication for the ER/LA analgesics to highlight appropriate patient selection rather than severity of pain and orders post-marketing studies to identify a dose and duration-of-treatment associated with higher rates of abuse, misuse, addiction, overdose and death.
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.